Mohamed, A.G.; Badawy, H.F.; Said, A.S.A.; Al-Ahmad, M.M.; Rabie, A.S.I.; Salah, H.; Massoud, R.; Hussein, R.R.S.; Khalil, D.M.; Yousef, A.;
et al. Additive Value of Pyridostigmine to Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia: A Randomized Controlled Trial. J. Clin. Med. 2025, 14, 674.
https://doi.org/10.3390/jcm14030674
AMA Style
Mohamed AG, Badawy HF, Said ASA, Al-Ahmad MM, Rabie ASI, Salah H, Massoud R, Hussein RRS, Khalil DM, Yousef A,
et al. Additive Value of Pyridostigmine to Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia: A Randomized Controlled Trial. Journal of Clinical Medicine. 2025; 14(3):674.
https://doi.org/10.3390/jcm14030674
Chicago/Turabian Style
Mohamed, Ahmed G., Hany F. Badawy, Amira S. A. Said, Mohammad M. Al-Ahmad, Al Shaimaa Ibrahim Rabie, Hager Salah, Ramy Massoud, Raghad R. S. Hussein, Doaa Mahmoud Khalil, Ahmed Yousef,
and et al. 2025. "Additive Value of Pyridostigmine to Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia: A Randomized Controlled Trial" Journal of Clinical Medicine 14, no. 3: 674.
https://doi.org/10.3390/jcm14030674
APA Style
Mohamed, A. G., Badawy, H. F., Said, A. S. A., Al-Ahmad, M. M., Rabie, A. S. I., Salah, H., Massoud, R., Hussein, R. R. S., Khalil, D. M., Yousef, A., & Ibrahim, R. M.
(2025). Additive Value of Pyridostigmine to Silodosin in the Management of Acute Urinary Retention Secondary to Benign Prostatic Hyperplasia: A Randomized Controlled Trial. Journal of Clinical Medicine, 14(3), 674.
https://doi.org/10.3390/jcm14030674